医学
病因学
浆液性液体
胸腔积液
回顾性队列研究
内科学
渗出
胃肠病学
间皮瘤
病理
外科
作者
Inés Losada-López,Juan González‐Moreno,Nuria Roda,Lola Ventayol,Yolanda Borjas,Francisco J. Domínguez,Victoria Fernández‐Baca,Mercedes García‐Gasalla,Antoni Payeras
摘要
Abstract Background Polyserositis (PS) is the inflammation, with effusion, of different serous membranes. It has been associated with different aetiologies, but the aetiology of PS remains unknown in a high percentage of patients. Aims The general objective of this retrospective study was to analyse the aetiology of PS cases seen at Son Llàtzer Hospital in an 11‐year period. Other objectives were to determine the epidemiological, clinical and analytical characteristics of these patients. Methods An observational, descriptive and retrospective study to analyse the aetiology of PS cases seen at Son Llàtzer Hospital. The inflammation of two or more serous membranes confirmed by an imaging test was required and at least one of the serous fluid should be an exudate. Results A total of 92 patients was included in the study. The most common diagnosis was neoplasm (nearly one‐third of cases) followed by infectious and autoimmune diseases. PS aetiology was unknown in more than one‐third. Pleura and pericardium were the most common sites of serosal involvement (83%). Antinuclear antibodies’ positivity in serum and increased levels of adenosine deaminase in pleural effusion were significantly associated with a final diagnosis of autoimmune disease. Increased pleural lactate dehydrogenase levels were significantly associated with a final diagnosis of neoplasm. In 9 of 14 patients with a previous cancer, PS represented a recurrence of their cancer. Cases of unknown aetiology presented most frequently as pleural and pericardial involvement, and the majority resolved. In very few patients, an infectious aetiology could be proven. Conclusion PS is a frequent clinical entity that is associated with different diseases and its diagnosis could be challenging, with a high rate of unknown aetiologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI